These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10822520)

  • 1. Hostility in patients with chronic constipation.
    Dumitraşcu DL; Acalovschi M; Pascu O
    Rom J Intern Med; 1998; 36(3-4):239-43. PubMed ID: 10822520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of abdominal bloating to distention in irritable bowel syndrome and effect of bowel habit.
    Houghton LA; Lea R; Agrawal A; Reilly B; Whorwell PJ
    Gastroenterology; 2006 Oct; 131(4):1003-10. PubMed ID: 17030170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Irritable bowel syndrome: an international study of symptoms in eight countries.
    Gerson CD; Gerson MJ; Awad RA; Chowdhury A; Dancey C; Poitras P; Porcelli P; Sperber A; Wang WA
    Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):659-67. PubMed ID: 18679069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daily stress and gastrointestinal symptoms in women with irritable bowel syndrome.
    Hertig VL; Cain KC; Jarrett ME; Burr RL; Heitkemper MM
    Nurs Res; 2007; 56(6):399-406. PubMed ID: 18004186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective study of unexplained visible abdominal bloating.
    Sullivan SN
    N Z Med J; 1994 Oct; 107(988):428-30. PubMed ID: 7970340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of withdrawing tegaserod treatment in comparison with continuous treatment in irritable bowel syndrome patients with abdominal pain/discomfort, bloating and constipation: a clinical study.
    Bardhan KD; Forbes A; Marsden CL; Mason T; Short G
    Aliment Pharmacol Ther; 2004 Jul; 20(2):213-22. PubMed ID: 15233702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea.
    Talley NJ; Dennis EH; Schettler-Duncan VA; Lacy BE; Olden KW; Crowell MD
    Am J Gastroenterol; 2003 Nov; 98(11):2454-9. PubMed ID: 14638348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personality patterns seen in irritable bowel syndrome patients.
    Bergeron CM; Monto GL
    Am J Gastroenterol; 1985 Jun; 80(6):448-51. PubMed ID: 4003373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients with irritable bowel syndrome and constipation are more depressed than patients with functional constipation.
    Bouchoucha M; Hejnar M; Devroede G; Boubaya M; Bon C; Benamouzig R
    Dig Liver Dis; 2014 Mar; 46(3):213-8. PubMed ID: 24252578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of irritable bowel syndrome. A case control experience.
    Astegiano M; Pellicano R; Terzi E; Simondi D; Rizzetto M
    Minerva Gastroenterol Dietol; 2006 Dec; 52(4):359-63. PubMed ID: 17108865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychological evaluation of patients with severe idiopathic constipation: which instrument to use.
    Wald A; Burgio K; Holeva K; Locher J
    Am J Gastroenterol; 1992 Aug; 87(8):977-80. PubMed ID: 1642221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensation of bloating and visible abdominal distension in patients with irritable bowel syndrome.
    Chang L; Lee OY; Naliboff B; Schmulson M; Mayer EA
    Am J Gastroenterol; 2001 Dec; 96(12):3341-7. PubMed ID: 11774947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation among personality and symptoms in nonulcer dyspepsia and the irritable bowel syndrome.
    Talley NJ; Phillips SF; Bruce B; Twomey CK; Zinsmeister AR; Melton LJ
    Gastroenterology; 1990 Aug; 99(2):327-33. PubMed ID: 2365186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.
    Ducrotte P; Dapoigny M; Bonaz B; Siproudhis L
    Aliment Pharmacol Ther; 2005 Feb; 21(4):435-44. PubMed ID: 15709995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abdominal symptoms and anorectal function in health and irritable bowel syndrome.
    Ragnarsson G; Hallböök O; Bodemar G
    Scand J Gastroenterol; 2001 Aug; 36(8):833-42. PubMed ID: 11495079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum serotonin concentration and urine 5-hydroxyindole acetic acid excretion in patients with irritable bowel syndrome].
    Moskwa A; Chojnacki J; Wiśiewska-Jarosińska M; Stec-Michalska K; Szadkowski K; Smigielski J; Chojnacki C
    Pol Merkur Lekarski; 2007 May; 22(131):366-8. PubMed ID: 17679369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a laxative with and without tegaserod in adolescents with constipation predominant irritable bowel syndrome.
    Khoshoo V; Armstead C; Landry L
    Aliment Pharmacol Ther; 2006 Jan; 23(1):191-6. PubMed ID: 16393297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subtyping the irritable bowel syndrome by predominant bowel habit: Rome II versus Rome III.
    Ersryd A; Posserud I; Abrahamsson H; Simrén M
    Aliment Pharmacol Ther; 2007 Sep; 26(6):953-61. PubMed ID: 17767480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive factors of irritable bowel syndrome improvement: 1-year prospective evaluation in 400 patients.
    Mearin F; Badía X; Balboa A; Benavent J; Caballero AM; Domínguez-Muñoz E; Garrigues V; Piqué JM; Roset M; Cucala M; Figueras M;
    Aliment Pharmacol Ther; 2006 Mar; 23(6):815-26. PubMed ID: 16556184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of bowel symptoms with colonic transit, length, and faecal load in functional faecal retention.
    Raahave D; Christensen E; Loud FB; Knudsen LL
    Dan Med Bull; 2009 May; 56(2):83-8. PubMed ID: 19486620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.